Biotech firms rush to enter CRISPR crop market to meet global food demand

| | April 19, 2019
canola oil
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Agriculture technology (“agtech”) companies of all sizes are vying to enter commercial food markets. [In March] when news broke about the first successful food made with a gene-edited crop, some suggested this new technology could leave genetically modified foods (along with their controversies and regulations) “in the dust.” Various stories focused on the startup Calyxt’s first commercial sale of Calyno high oleic soybean oil to the foodservice industry.

Related article:  Gene drives reach their next frontier: Mammals

Now, the commercialization of gene-edited foods (or as Calyxt dubs it, “concept to fork”) is one step closer to reality.

Why is the race on to advance gene-edited food for commercial purposes? Dr. Oliver Peoples, CEO of Yield10 Bioscience, a player in this evolving field, explained in an interview with TriplePundit:

“Enhancing global food security through improved seed yield and crop resilience is key to ensuring we’re able to produce enough food and feed, using the space and resources that we have available.”

Yield10 says it has been working to improve seed yield in commercial oilseed crops to tap into emerging market opportunities and address unmet needs for global food security….

Read full, original article: Gene-Edited Foods Just Took a Big Step Toward Commercialization

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend